| Financial Year |
March 31 2023 |
| Monetary Funds |
183,449,296.54 |
| Held-for-trading Financial Assets |
11,004,217.93 |
| Notes Receivable |
-- |
| Accounts Receivable |
460,901,549.00 |
| Advances to Suppliers |
90,367,719.60 |
| Other Receivables |
117,970,146.91 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,531,131,045.74 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
23,987,852.97 |
| Total Current Assets |
3,418,811,828.69 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
7,796,922.98 |
| Investment Properties |
-- |
| Fixed Assetes |
2,173,782,126.72 |
| Under-construction Projects |
97,073,510.66 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,932,502,725.77 |
| R&D expenses |
-- |
| Goodwill |
47,736,079.25 |
| Long-Term Deferred and Prepaid Expenses |
1,848,594.62 |
| Deferred Income Tax Assets |
887,724,794.85 |
| Other Non-Current Assets |
2,394,701.38 |
| Sub-Total of Non-Current Assets |
7,316,497,143.32 |
| Total Assets |
10,735,308,972.01 |
| Short-Term Loans |
232,992,539.34 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
2,111,241,584.52 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
89,334,431.03 |
| Taxes Payable |
8,050,934.68 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
109,961,425.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,147,669,074.89 |
| Other Current Liabilities |
1,078,874.88 |
| Sub-Total of Current Liabilities |
3,726,237,849.27 |
| Long-term Loans |
1,731,820,225.06 |
| Bonds Payable |
969,202,865.07 |
| Long-Term Accounts Payable |
156,070,183.09 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,181,187,970.82 |
| Other Non-Current Liabilities |
3,072,002,936.58 |
| Sub-Total of Non-Current Liabilities |
7,241,830,484.02 |
| Total Liabilities |
10,968,068,333.29 |
| Paid-In Capital(Or Share Stock) |
174,200,000.00 |
| Capital Surplus |
746,132,255.20 |
| Surplus Reserve |
-- |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,686,229,674.02 |
| Minority Stockholder's Interest |
215,654,917.78 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-448,414,279.06 |
| Owner's Equity（Stockholder's Equity） |
-232,759,361.28 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,735,308,972.01 |
